Claraphi Advisory Network’s Charles River Laboratories CRL Stock Holding History

Claraphi Advisory Network’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-708	Closed	-$292K	–	299
2021 Q3	$292K	Buy	+708	New	+$294K	0.1%	220
2020 Q3	–	Sell	-1,163	Closed	-$203K	–	260
2020 Q2	$203K	Buy	1,163 +9	+0.8%	+$1.44K	0.09%	239
2020 Q1	$146K	Buy	+1,154	New	+$173K	0.07%	254
2019 Q2	–	Sell	-1,432	Closed	-$208K	–	244
2019 Q1	$208K	Buy	+1,432	New	+$188K	0.13%	205
2018 Q4	–	Sell	-1,943	Closed	-$262K	–	219
2018 Q3	$262K	Buy	1,943 +115	+6%	+$14.2K	0.15%	194
2018 Q2	$206K	Buy	+1,828	New	+$198K	0.13%	232

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Claraphi Advisory Network's CRL Position: Q4 2021 in Review

Claraphi Advisory Network sold out of Charles River Laboratories (CRL) in Q4 2021, closing a stake of 708 shares — an estimated $292K sold.

Claraphi Advisory Network first reported a position in CRL in Q2 2018 and held it in 6 quarters. The position peaked at $292K in Q3 2021. 707 funds tracked by Wall St. Rank hold CRL as of Q4 2021.

Claraphi Advisory Network reported no remaining Charles River Laboratories position as of Q4 2021 after selling out during the quarter.
Claraphi Advisory Network sold 708 Charles River Laboratories shares in Q4 2021, an estimated $292K.
Claraphi Advisory Network first reported a position in Charles River Laboratories in Q2 2018 and held it in 6 quarters.
Claraphi Advisory Network's Charles River Laboratories position peaked at $292K in Q3 2021.
707 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2021.

Based on Claraphi Advisory Network's 13F filing for Q4 2021, filed 7 Feb 2022.